Understanding how a mitochondrial protein makes decisions that affect cell health

Investigating the mechanism of decision-making in the mitochondrial Protease YME1

NIH-funded research Scripps Research Institute, the · NIH-11013784

This study is looking at a protein called YME1 that helps keep our cells healthy by managing how proteins are handled in the mitochondria, which is important for preventing diseases like Alzheimer's, and it aims to learn more about how YME1 makes choices that affect our health as we age.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionScripps Research Institute, the NIH-funded
Lab location1 site (La Jolla, United States)
Project IDNIH-11013784 on NIH RePORTER

What this research studies

This research investigates the role of the YME1 protein, an ATP-dependent protease located in the mitochondria, in maintaining cellular health by managing protein quality control. It focuses on how YME1 makes molecular decisions to either degrade or cleave mitochondrial substrates, which is crucial for preventing diseases like Alzheimer's and other neurodegenerative disorders. By exploring the mechanisms behind YME1's decision-making, the research aims to uncover new insights into mitochondrial function and its implications for age-related diseases.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals at risk for or diagnosed with age-related neurodegenerative diseases, especially Alzheimer's.

Not a fit: Patients with non-age-related conditions or those without mitochondrial dysfunction may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating neurodegenerative diseases, particularly Alzheimer's.

How similar studies have performed: Previous research has shown promising results in understanding mitochondrial functions and their implications in neurodegenerative diseases, indicating that this approach has potential for success.

Where this research is happening

La Jolla, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.